Skip to content
★ Sign in to follow
MB

Michael Berman

Board Director
Director
InspireMD, Inc.
Total declarations
17
Company
1
▲ Purchases (3 ops.)
€270k
▼ Sales (0 ops.)
—

Latest filing published 16 Jan 2026 for InspireMD, Inc..

Filing timeline

BuySale
Michael Berman

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

Closed purchases

Market purchases
3
Positive at T+90
50%
Median T+90
+1.9%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 16 May 2023 · 1273 days ago · €183k
    +30.7%
    Entry US$1.76 · Close at T+365 US$2.30
  • Filed 10 Feb 2021 · 2098 days ago · €41k
    -86.4%
    Entry US$19.65 · Close at T+365 US$2.68

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Michael Berman: trading record in brief

All filings by Michael Berman on record concern InspireMD, Inc., in the capacity of board member. In total, 17 filings cover trades dated from 16 April 2013 to 14 January 2026.

On the market, this insider has only ever bought: 3 purchases, €270k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 14 share grants.

In size, the median ticket on the buying side is €46k.

The newest entry dates from 16 January 2026: a share grant, in InspireMD, Inc. The latest purchase dates back some time: it was published 1,273 days ago, on 16 May 2023. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Michael Berman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total

17 of 17 declarations